Nektar Therapeutics — Balance Sheet (NASDAQ:NKTR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 1.54 B1.12 B710.6 M398.03 M303.85 M Total liabilities 461.47 M437.68 M343.96 M267.05 M243.11 M Total equity 1.08 B679.51 M366.64 M130.99 M60.74 M Total liabilities & shareholders' equities 1.54 B1.12 B710.6 M398.03 M303.85 M Total debt ————— Net debt —————

News

Oppenheimer raises Nektar Therapeutics price target to $140

Nektar Therapeutics stock hits 52-week high at 76.3 USD

Earnings call transcript: Nektar Therapeutics Q4 2025 shows cash boost and R&D expansion

Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates

Esperion Therapeutics (ESPR) Misses Q4 Earnings Estimates

Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for

Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet

Nektar Therapeutics stock hits 52-week high at 75.19 USD

Nektar Therapeutics closes $460 million public offering

Nektar Stock Surges On Rezpegaldesleukin Phase 2b Maintenance Data: What It Means

Micron, Palantir among market cap stock movers on Wednesday

Nektar (NKTR) Soars 51.1%: Is Further Upside Left in the Stock?